Molecular Characteristics of IDH2-Mutated, Philadelphia Chromosome-Negative, Advanced-Phase Myeloproliferative Neoplasms Treated with Enasidenib-MedSci.cn - 梅斯（MedSci）

Molecular Characteristics of IDH2-Mutated, Philadelphia Chromosome-Negative, Advanced-Phase Myeloproliferative Neoplasms Treated with Enasidenib

Patel, A; Cahill, K; Charnot-Katsikas, A; Liu, HT; Gurbuxani, S; Thirman, M; Kosuri, S; Larson, R; Stock, W; Segal, J; Odenike, O

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020; 20 (): S335

科室
- - 订阅+
  - 更多科室
工具
服务